OncXerna Therapeutics, Inc.
PrivateLast Round
Series B
Jan 28, 2021
Total Funding Raised
$126.5M
Company Overview
OncXerna Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Series B round in January 2021.
OncXerna Therapeutics, Inc. is a biotechnology company that develops targeted oncology therapies by leveraging an RNA-expression based biomarker platform to match patients with specific treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncXerna Therapeutics, Inc. Comparables
Compare OncXerna Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cofactor Genomics | 84% | |
| BostonGene | 81% | |
| Strata Oncology | 80% |
For institutional investors. Book with your work email.
OncXerna Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2021 | ||||
| Series B | Jun 10, 2019 | ||||
| Seed | Jun 7, 2018 |
For institutional investors. Book with your work email.
OncXerna Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Bank | Seed |
| Korea Investment Partners | Series B |
| Bencao Capital | Series B |
| Nan Fung Life Sciences | Series B, Seed |
| Volcanics Venture | Seed |
| Panacea Venture Healthcare | Series B |
| Pivotal bioVenture Partners China | Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$30M round with participation from Nan Fung Life Sciences and Bencao Capital.
- Jun 7, 2018
$17M round led by Pivotal bioVenture Partners China.
For institutional investors. Book with your work email.
OncXerna Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncXerna Therapeutics, Inc.'s valuation, stock price, and market status.
Is OncXerna Therapeutics, Inc. a public or private company?
OncXerna Therapeutics, Inc. is a private company.
What is the current stock price of OncXerna Therapeutics, Inc.?
OncXerna Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks OncXerna Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncXerna Therapeutics, Inc. worth (valuation)?
Valuation information for OncXerna Therapeutics, Inc. is not publicly available.
Can I buy OncXerna Therapeutics, Inc. stock?
OncXerna Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncXerna Therapeutics, Inc.'s last funding round?
OncXerna Therapeutics, Inc.'s most recent funding round was Series B on January 28, 2021.
Who are the main investors in OncXerna Therapeutics, Inc.?
Key investors in OncXerna Therapeutics, Inc. include Nan Fung Life Sciences, Pivotal bioVenture Partners China.
Will OncXerna Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for OncXerna Therapeutics, Inc..
How can I track OncXerna Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OncXerna Therapeutics, Inc.'s shares on secondary markets.